3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Inflammatory Bowel Diseases
2
Crohn Disease
2
Colitis, Ulcerative
2
Lymphoma
1
Kidney Transplantation
1
Hematologic Neoplasms
1
Granulomatous Disease, Chronic
1
Graft vs Host Disease
1
Depressive Disorder, Treatment-Resistant
1
Depressive Disorder, Major
1
Depression
1
Bronchiolitis Obliterans Syndrome
1
Bipolar Disorder
1
Interventions
Therapeutics
6
Escitalopram
4
Yoga
3
Surveys and Questionnaires
3
Sugars
2
Psychiatric Rehabilitation
2
Psilocybin
2
Ketamine
2
Vorinostat
1
Ultraviolet Therapy
1
Typhoid-Paratyphoid Vaccines
1
Therapeutic Touch
1
Temozolomide
1
Self-Help Groups
1
Selective Serotonin Reuptake Inhibitors
1
Saline Solution
1
Psychosocial Intervention
1
Niacin
1
Minocycline
1
Methylphenidate
1
Melatonin
1
Massage
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Interleukin-2
1
Infliximab
1
Imagery, Psychotherapy
1
Fatty Acids, Omega-3
1
Exercise Test
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Depression
×
Infliximab
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts